Urolithin A Market

The >98% purity grade segment is estimated to account for 63.2% of 2026 demand, followed by anti-aging and mitochondrial health at 46.2% and capsules at 49.1%. Human mitochondrial research supports measured daily use, although separate food approvals and claim rules limit broader commercial launches.